Improving Services and Outcomes for Joint Replacement Patients
NCT ID: NCT01899443
Last Updated: 2017-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1900 participants
OBSERVATIONAL
2013-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
JOINTS Study - Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites
NCT00499278
Arthroplasty and Modifiable Risk Factors
NCT05399186
Subtalar Arthrodesis by Single Versus Double Screws
NCT05795543
A Trial Comparing Mini-posterior Approach and Direct Anterior Approach
NCT01024309
Study Evaluating the Efficacy of Joint Replacement
NCT04691466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is a longitudinal cohort study to examine outcomes after total hip and knee replacement surgeries. We hypothesise the site and patient level compliance is related to the prevalence of a subsequent complication (composite outcome comprising 30 day mortality, readmission, reoperation or surgical complication).
METHODS This study will select high volume (\>275 cases annually) public and private hospitals across Australia. By involving public and private sites across Australia, the generalisability of the findings is enhanced. Each site will identify a site coordinator to oversee and manage the project at that site. Site coordinators are identified by each site. After hospital discharge, patients are followed up by the investigators.
This is a prospective observational study with projected sample of c.2200 consenting patients from up to 20 high volume hospitals. The site coordinator will screen, approach and consent eligible patients during routine preadmission processes. At the time of consent, the patient will be required to: provide socio-demographic details about themselves, past medical history, complete 2 standard patient reported outcome measures. Contact with patients about the study will be made by the site coordinator and routine hospital staff involved in their acute care. Acute data collection will involve prospective audit of medical records to collect peri- and post- operative acute care process data, client characteristics and outcomes by staff at each site. Random and convenience sampling will be used to identify eligible hospital sites which will remain anonymous.
Patient follow up regarding longer term outcomes will be completed via telephone by study investigators at three additional time points (approximately 35 and 90 days and 1 year post surgery) to collect repeat data as provided by each patient at the time of consent.
Descriptive statistics will be used to profile site level and patient level compliance with key processes of care. Multivariable logistic regression (MLoR) will be used to identify the association between the binary composite outcome measure and patient level compliance. Site and individual patient compliance with evidence based guidelines (where available) or best practice recommendations on key processes and relevant outcomes will be examined (e.g. Venous thromboembolism (VTE) prevention). Sample size calculations have been completed to ensure the analyses have sufficient power. If a useful association between processes and outcomes is identified, cost analyses with specific foci will be undertaken to consider costs for different factors and stages (e.g. acute / post discharge). Secondary analysis will determine the predictors of patient -reported outcomes. Depending on the results of initial data analyses, additional secondary analyses will potentially include analyses at additional time points (beyond initial 35 days) for association between key processes and outcomes, and analysis looking at the association between specific complications and compliance with specific processes.
Interim analysis will be undertaken to assess the level of observed compliance with key processes.
Re-abstraction of acute care data will be undertaken to ensure accuracy and completeness of submitted date from the sites.
Site survey Prior to study commencement at each site, the site coordinators will complete a survey detailing each surgeons protocols for key processes including their VTE and antimicrobial prophylaxes. The extent surgeon protocols align with Australian practice guidelines will be ascertained.
Additional secondary analyses will include, but may not be limited to:
1. a comparison of outcomes between patients who go to inpatient rehabilitation and those who go directly home after surgery. Propensity based scoring and matching will be used to determine if outcomes are better in one of the two groups
2. determination of the predictors of the 'unhappy knee' 12 months post surgery. A case controlled matched design will be used.
3. comparison in satisfaction with the acute care experience between private and public patients in a subset
4. a comparison of outcomes between THR patients with an anterior surgical approach and a posterior approach
5. description of ambulation profiles immediately post surgery and variables associated with early ambulation
6. snapshot of rehabilitation received after TKA or THA
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total hip and knee replacement patients
This study will select up to 20 high volume (\>275 cases annually) public and private hospitals across Australia. A random sample of c.2200 patients with diagnosis of osteoarthritis undergoing primary total hip or knee replacement surgery will be recruited.
Observation
This is an observational study observing relationship between routine care and outcomes after total hip or knee arthroplasty.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
This is an observational study observing relationship between routine care and outcomes after total hip or knee arthroplasty.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary diagnosis of osteoarthritis
* Aged 18 or over, either gender
* Able to comprehend the protocol and provide consent (e.g. be able to read English, have no history of dementia)
* Available for telephone follow-up within the first 6 weeks, 3 months and then at 12 months post surgery
* No further joint replacement surgery planned within the next 3 months of the current surgery
Exclusion Criteria
* Hip replacement for fracture
* Revision of previous joint replacement
* Under 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South West Sydney Local Health District
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Justine Naylor
Senior Principal Research Fellow; Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Justine M Naylor, PhD,BAppSc (Phty)
Role: PRINCIPAL_INVESTIGATOR
Sydney South West Local health District, University of NSW, Ingham Institute for Applied Medical Research
Ian A Harris, PhD,MBBS
Role: PRINCIPAL_INVESTIGATOR
Sydney South West Local health District, University of NSW, Ingham Institute for Applied Medical Research
Helen M Badge, MApSc,BAScOT
Role: PRINCIPAL_INVESTIGATOR
Ingham Institute for Applied Medical Research, University of NSW
Wei Xuan, PhD
Role: PRINCIPAL_INVESTIGATOR
Ingham Institute Applied Medical Research
Christine Lin, PhD, BApScPhty
Role: PRINCIPAL_INVESTIGATOR
George Institute, University of Syndey, Australia
Elizabeth Armstrong, BAppScPhty
Role: PRINCIPAL_INVESTIGATOR
University of NSW, Sydney, Australia
Kevin Bozic, MD MBA
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
John Fletcher, PhD, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Sydney, Australia
Iain Gosbell, PhD, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Western Sydney, Australia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Concealed site 4 Public
Rural, New South Wales, Australia
Concealed site 6 Private
Rural, New South Wales, Australia
Concealed site 8 Private
Rural, New South Wales, Australia
Concealed site 16 Public
Semi Rural, New South Wales, Australia
Concealed site 1 Public
Sydney, New South Wales, Australia
Concealed site 17 Private
Sydney, New South Wales, Australia
Concealed site 2 Public
Sydney, New South Wales, Australia
Concealed Site 3 Public
Sydney, New South Wales, Australia
Concealed site 5 Private
Sydney, New South Wales, Australia
Concealed site 7 Private
Urban, New South Wales, Australia
Concealed site 15 Public
Rural, Queensland, Australia
Concealed site 13 Private
Urban, Queensland, Australia
Concealed site 14 Public
Urban, Queensland, Australia
Concealed site 12 Private
Urban, South Australia, Australia
Concealed site 11 Private
Urban, Tasmania, Australia
Concealed site 9 Private
Melbourne, Victoria, Australia
Concealed site 10 Public
Urban, Victoria, Australia
Concealed site 18 - 2 Public sites
Urban, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Johns N, Naylor J, McKenzie D, Brady B, Olver J. High pain reported at 3 months post-total knee arthroplasty often persists for the next 3 years and is associated with reduced function and quality of life. Musculoskeletal Care. 2024 Mar;22(1):e1866. doi: 10.1002/msc.1866.
Sidhu V, Badge H, Churches T, Maree Naylor J, Adie S, A Harris I. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study. BMC Musculoskelet Disord. 2023 Aug 3;24(1):629. doi: 10.1186/s12891-023-06750-x.
Jenkin DE, Harris IA, Descallar J, Naylor JM. Discharge to inpatient rehabilitation following arthroplasty is a strong predictor of persistent opioid use 90 days after surgery: a prospective, observational study. BMC Musculoskelet Disord. 2023 Jan 14;24(1):31. doi: 10.1186/s12891-023-06142-1.
Johns N, Naylor J, McKenzie D, Brady B, Olver J. Is inpatient rehabilitation a predictor of a lower incidence of persistent knee pain 3-months following total knee replacement? A retrospective, observational study. BMC Musculoskelet Disord. 2022 Sep 12;23(1):855. doi: 10.1186/s12891-022-05800-0.
Naylor JM, Hart A, Mittal R, Harris IA, Xuan W. The effectiveness of inpatient rehabilitation after uncomplicated total hip arthroplasty: a propensity score matched cohort. BMC Musculoskelet Disord. 2018 Jul 18;19(1):236. doi: 10.1186/s12891-018-2134-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISOAJRS_AU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.